UKNSCN STEERING COMMITTEE MEMBERS
The UKNSCN Steering Committee comprises eight members and has an independent Chairman. The Chairman is appointed for two years, and members for an initial term of one year with the possibility of extension to two. The Steering Committee meets quarterly and is the main body responsible for the governance of the UK National Stem Cell Network and its activities. Its first chairman is Lord Naren Patel of Dunkeld, supported by eight members listed below.
Chairman Lord Naren Patel of Dunkeld (independent) [biography]
Lord Naren Patel is Professor and Consultant at the University of Dundee, Ninewells Hospital, Dundee. Born in Tanzania he graduated in medicine at the University of St. Andrews, Scotland, in 1964. He is currently Chairman of the United Kingdom Stem Cell Oversight Committee and Chairman of the National Patient Safety Agency of the United Kingdom and Chancellor of the University of Dundee.
Previously he has held the position of Chairman of the Academy of Medical Royal Colleges of Scotland and the United Kingdom; member of the Council of the General Medical Council and Academy of Medical Sciences and was Chairman of the Genetic Advisory Committee of the Medical Research Council of the United Kingdom.
He was awarded a Knighthood in the Queen's Birthday Honours List in 1997 and was made a life Peer with the title of Baron Patel of Dunkeld in Perth and Kinross in the Queen's New Years Honours List in 1999. He has been a member of the Scientific and Technology Committee of the House of Lords since 1999 and is a patron of several charities and a Board Member of several others.
Members Professor Sir Martin Evans FRS FMedSci, University of Cardiff [biography]
Sir Martin Evans is Professor of Mammalian Genetics of Cardiff University, Fellow of the Royal Society and Fellow of the Academy of Medical Sciences. After graduating from Cambridge in 1963 he decided on a career studying the genetic control of vertebrate development and undertook research for his PhD at University College London in the department of Anatomy and Embryology.
He was the first to maintain mouse teratocarcinoma stem cells in tissue culture under conditions where their ability to differentiate was retained indefinitely.
In 1981 after his return to Cambridge that together with Matt Kaufman he was able to isolate similar cells from normal mouse embryos. These cells which became known as "Embryonic Stem Cells" (ES cells) were able to be used to fully regenerate fertile breeding mice from the tissue culture cells and that these could therefore carry mutations introduced and selected or screened for in culture. This is now the basis for experimental mammalian genetics - of mouse knockout and targetted genetic manipulation.
Sir Martin received the Lasker award in 2001 and was knighted in 2004 for services to Medical Science.
Professor Jon Frampton, University of Birmingham [biography]
For almost two decades Professor Frampton has been investigating the molecular mechanisms controlling blood stem cells in the bone marrow. After obtaining a doctorate in Cambridge he carried out research in Glasgow, Heidelberg and Oxford before his appointment in 2004 as Professor of Stem Cell Biology at the University of Birmingham.
Dr Chris Mason FRCS, University College London [biography]
Originally trained as a surgeon, Dr Mason now heads up the Stem Cell and Regenerative Medicine Bioprocessing Unit in the Advanced Centre for Biochemical Engineering, UCL. Chris is also involved in a number of committees, networks, scientific advisory boards, editorial boards, working groups and initiatives related to the academic, clinical and commercial advancement of regenerative medicine.
Professor Roger Pedersen, University of Cambridge [biography]
Professor Pedersen received degrees in biology from Stanford (A.B, 1965) and Yale (PhD, 1970) and did postdoctoral work at Johns Hopkins. In 1971, he joined the University of California, San Francisco, where he studied developmental potency and fate in mammalian embryos. In 2001 he moved to the University of Cambridge, where he continues his research on human embryonic stem cells as Professor of Regenerative Medicine.
Professor Dame Julia Polak FRS, Imperial College [biography]
Professor Polak graduated in Buenos Aires, Argentina and obtained her postgraduate training in the UK. She became Professor and the Director of Tissue Engineering and Regenerative Medicine Centre, Imperial College in 1997.
She is a member of the Stem Cell Advisory Board Panel of the joint MRC/UKSCF, Panel of the new EPSRC Peer Review College (2006 - 2009), Panel of the MRC College of Experts (2006 - 2010) and Steering Group of the UK Stem Cell Immunology Programme (March 2006). She is a council member of the Tissue Engineering Society International and the Academy of Medical Sciences (2002 - 2005) and was also European Editor of Tissue Engineering (up until 2004).
She is the author of more than 1000 original papers, 127 review articles and Editor/Author of 25 books and is one of the most Highly Cited Researchers inher field. She is a co-founder and Director of a spin out company, Novathera, dealing with Regenerative Medicine Products.
She has received a number of honours and won a number of prizes. She was made Dame Commander of the British Empire (DBE) in 2003.
Professor Brian Salter, University of East Anglia [biography]
Professor Salter is Professor of Biopolitics and Director of the Global Biopolitics Research Group in the Institute of Health at the University of East Anglia. A political scientist specialising in the analysis of public policy, his work focuses on the global politics and governance of new health technologies.
Professor Michael Whitaker FIBiol FMedSci, University of Newcastle-Upon-Tyne [biography]
Professor Whitaker has a background and international reputation in physiology, biochemistry, cell and developmental biology and reproduction. He has long-standing links with the Wellcome Trust and has served on the boards of a number of companies and learned societies in the life science sector. He has recently established the Northeast England Institute Stem Cell Institute (NESCI) as a joint venture between Durham and Newcastle Universities.
Mr Hugh Ilyine, Stem Cell Sciences Limited [biography]
Mr Ilyine is a director of Stem Cell Sciences plc, and acts in the capacity of Vice President and Chief Operating Officer with the company, responsible for the global operations. Prior to joining SCS in 2000, Mr Ilyine was General Manager of the BioSciences Division of Bonlac Foods, Australia. Prior to this Mr Ilyine spent seventeen years with the Rhone-Poulenc group of companies in various international marketing and company managing director roles in France, Indonesia and Australia.
He brings considerable international experience in developing companies and their IP, licensing, product development and operational management. Mr Ilyine is a member of the Advisory Board of the Scottish Stem Cell Network.
Return to top of page
|
